2023-02-27
On February 26th, 2023, Baheal Medical announced that it had recently signed a strategic cooperation agreement with Novartis China. The two parties will engage in an in-depth cooperation related to the commercial operation of Novartis' targeted therapy drug Votrient® (Pazopanib Tablets) for the first-line treatment of advanced renal cell carcinoma in the Chinese market.